Alejandro Dorenbaum Reneo Pharmaceuticals, Inc. (RPHM) insider trading activity
Alejandro Dorenbaum is Chief Medical Officer of Reneo Pharmaceuticals, Inc.. Currently has a direct ownership of 30,000 shares of RPHM, which is worth approximately $50,400. The most recent transaction as insider was on Aug 12, 2022, when has been sold 22,348 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
30K
0%
3M change
0%
12M change
Total Value Held
$50,400
AD
Alejandro Dorenbaum
Chief Medical Officer
Irvine, CA